Largest study using machine learning in neuroimaging sets new benchmark for major depression diagnosis

A benchmark classification of major depressive disorder (MDD) using machine learning (ML).

Extended Paxlovid courses show mixed results for long COVID symptoms

A study indicates that longer Paxlovid treatments could improve long COVID symptoms in some patients, highlighting the need for tailored antiviral strategies.

January 8, 2025

Innovative nanoparticle therapy enhances recovery in severe burn patients

Severe burns can cause critical issues, including deep tissue damage and increased risk of fatal conditions like sepsis and organ failure.

March 13, 2024

Iovance closes $172.5M offering; Veklury approved for Covid-19 patients with severe renal disease

Just a few days after pricing a $150 million public offering, Iovance has now closed with 15% more raised, thanks to underwriters pitching in. Iovance

July 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.